Adolescent and Transition Medicine
Kahn Lab

Kahn Research Lab

The goal of the Kahn Lab is to conduct interdisciplinary clinical and epidemiologic studies related to prevention of cervical cancer and other diseases caused by human papillomavirus (HPV), in the United States and globally.

We have conducted studies that:

  • Examine the accuracy and acceptability of different collection methods for HPV DNA testing in adolescents
  • Explore the psychosocial and behavioral impact of HPV infection and abnormal Pap tests among adolescents
  • Define the epidemiology and risk factors for HPV infection in adolescents
  • Examine prevention of cervical cancer and other HPV-related diseases through HPV vaccination
    • Predictors of clinician recommendations and adolescent uptake of HPV vaccines 
    • Effect of HPV vaccination on sexual attitudes and behaviors
    • Impact of HPV vaccination on the epidemiology of HPV in the community
    • Safety, immunogenicity and effectiveness of HPV vaccination in immunocompromised populations
    • Feasibility of vaccination in less developed regions of the world 

Publications

Morales-Campos, DY; Zimet, GD; Kahn, JA. Human Papillomavirus Vaccine Hesitancy in the United States. Pediatric Clinics of North America. 2023; 70:211-226.

Morales-Campos, DY; Flores, BE; Donovan, E; Burdick, S; Parra-Medina, D; Kahn, JA. A qualitative descriptive study of providers' perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators. BMC Public Health. 2022; 22:443.

Real, FJ; Ollberding, NJ; Meisman, AR; DeBlasio, DJ; Pero, MB; Davis, D; Cruse, B; Klein, MD; Kahn, JA; Rosen, BL. Impact of a Virtual Reality Curriculum on Human Papillomavirus Vaccination: A Pilot Trial. American Journal of Preventive Medicine. 2022; 63:865-873.

Kahn, J; Washington, C; Ding, L; Wyllie, T; Rosen, B; Gorbach, P. Partner-Level and Sexual Networking Factors Are Associated With Vaccine-Type and Nonvaccine-Type Human Papillomavirus Infection After Vaccine Introduction in Young Women. Sexually Transmitted Diseases. 2022; 49:429-436.

Palefsky, JM; Lensing, SY; Belzer, M; Lee, J; Gaur, AH; Mayer, K; Futterman, D; Stier, EA; Paul, ME; Chiao, EY; et al. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus. Clinical Infectious Diseases. 2021; 73:1388-1396.

Hackworth, JM; Meinzen-Derr, J; DePalma, M; Hostetter, M; Klein, M; O'Toole, JK; Kahn, J. The Impact of Primary Mentors and Career Development Committees on Junior Faculty Productivity in a Pediatric Academic Health Center. The Journal of Pediatrics. 2021; 232:4-8.e1.

Rosen, BL; Gorbach, P; Ding, L; Covert, C; Ermel, AC; Chandler, E; Malagón, T; Kahn, JA. Sexual Network Patterns and Their Association With Genital and Anal Human Papillomavirus Infection in Adolescent and Young Men. Journal of Adolescent Health. 2021; 68:696-704.

Drolet, M; Bénard, É; Pérez, N; Brisson, M; HPV Vaccination Impact Study Group, . Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. The Lancet. 2019; 394:497-509.

Covert, C; Ding, L; Brown, D; Franco, EL; Bernstein, DI; Kahn, JA. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. Human Vaccines and Immunotherapeutics. 2019; 15:1962-1969.

Spinner, C; Ding, L; Bernstein, DI; Brown, DR; Franco, EL; Covert, C; Kahn, JA. Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women. Pediatrics. 2019; 143:e20181902.

Hackworth, J; Steel, S; Cooksey, E; DePalma, M; Kahn, JA. Faculty Members' Self-Awareness, Leadership Confidence, and Leadership Skills Improve after an Evidence-Based Leadership Training Program. The Journal of Pediatrics. 2018; 199:4-6.e2.

Chandler, E; Ding, L; Gorbach, P; Franco, EL; Brown, DA; Widdice, LE; Bernstein, DI; Kahn, JA. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction. Journal of Adolescent Health. 2018; 63:43-49.

Kahn, JA; Lee, J; Belzer, M; Palefsky, JM; Consortium, AI D S M; HIV, AM T N. HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination. AIDS and Behavior. 2018; 22:1826-1834.

Saccucci, M; Franco, EL; Ding, L; Bernstein, DI; Brown, D; Kahn, JA. Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection. Sexually Transmitted Diseases. 2018; 45:260-265.

Rosen, BL; Bishop, JM; McDonald, SL; Kahn, JA; Kreps, GL. Quality of Web-Based Educational Interventions for Clinicians on Human Papillomavirus Vaccine: Content and Usability Assessment. JMIR Cancer. 2018; 4:e3.

Mullins, TL K; Rosenthal, SL; Zimet, GD; Ding, L; Morrow, C; Huang, B; Kahn, JA. Human Papillomavirus Vaccine-Related Risk Perceptions Do Not Predict Sexual Initiation Among Young Women Over 30 Months Following Vaccination. Journal of Adolescent Health. 2018; 62:164-169.

Kahn, JA; Widdice, LE; Ding, L; Huang, B; Brown, DR; Franco, EL; Bernstein, DI. Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community. Clinical Infectious Diseases. 2016; 63:1281-1287.

Morales-Campos, DY; Zimet, GD; Kahn, JA. Human Papillomavirus Vaccine Hesitancy in the United States. Pediatric Clinics of North America. 2023; 70:211-226.

Meisman, AR; Sachdeva, YS; Real, FJ; Kahn, J; Rosen, BL. 170. Association between Social Determinants of Health and Completion of the HPV Vaccine Series. Journal of Adolescent Health. 2023; 72:s95-s96.

Morales-Campos, DY; Flores, BE; Donovan, E; Burdick, S; Parra-Medina, D; Kahn, JA. A qualitative descriptive study of providers' perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators. BMC Public Health. 2022; 22:443.

Real, FJ; Ollberding, NJ; Meisman, AR; DeBlasio, DJ; Pero, MB; Davis, D; Cruse, B; Klein, MD; Kahn, JA; Rosen, BL. Impact of a Virtual Reality Curriculum on Human Papillomavirus Vaccination: A Pilot Trial. American Journal of Preventive Medicine. 2022; 63:865-873.

Rosen, BL; Real, FJ; Bishop, JM; McDonald, SL; Klein, M; Kahn, JA; Kreps, GL. School Health Service Provider Perceptions on Facilitated Interactive Role-Play Around HPV Vaccine Recommendation. Journal of Cancer Education. 2022; 37:1286-1295.

Kahn, J; Washington, C; Ding, L; Wyllie, T; Rosen, B; Gorbach, P. Partner-Level and Sexual Networking Factors Are Associated With Vaccine-Type and Nonvaccine-Type Human Papillomavirus Infection After Vaccine Introduction in Young Women. Sexually Transmitted Diseases. 2022; 49:429-436.

Bishop, JM; Real, FJ; McDonald, SK Y E L; Klein, M; DeBlasio, DO M I N I C; Kahn, JA; Kreps, GL; Rosen, BL. Evaluation of HPV Vaccine: Same Way, Same DayTM: A Pilot Study. Journal of Health Communication: international perspectives. 2021; 26:839-845.

Palefsky, JM; Lensing, SY; Belzer, M; Lee, J; Gaur, AH; Mayer, K; Futterman, D; Stier, EA; Paul, ME; Chiao, EY; et al. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus. Clinical Infectious Diseases. 2021; 73:1388-1396.

Real, FJ; Rosen, BL; Bishop, JM; McDonald, S; DeBlasio, D; Kreps, GL; Klein, M; Kahn, JA. Usability Evaluation of the Novel Smartphone Application, HPV Vaccine: Same Way, Same Day, Among Pediatric Residents. Academic Pediatrics. 2021; 21:742-749.

Hackworth, JM; Meinzen-Derr, J; DePalma, M; Hostetter, M; Klein, M; O'Toole, JK; Kahn, J. The Impact of Primary Mentors and Career Development Committees on Junior Faculty Productivity in a Pediatric Academic Health Center. The Journal of Pediatrics. 2021; 232:4-8.e1.

Rosen, BL; Gorbach, P; Ding, L; Covert, C; Ermel, AC; Chandler, E; Malagón, T; Kahn, JA. Sexual Network Patterns and Their Association With Genital and Anal Human Papillomavirus Infection in Adolescent and Young Men. Journal of Adolescent Health. 2021; 68:696-704.

Reed, JL; Alessandrini, EA; Dexheimer, J; Kachelmeyer, A; Macaluso, M; Zhang, N; Kahn, JA. Effectiveness of a Universally Offered Chlamydia and Gonorrhea Screening Intervention in the Pediatric Emergency Department. Journal of Adolescent Health. 2021; 68:57-64.

DePalma, M; Kurowski, B; Hackworth, J; Steel, S; Kahn, J. Sustained Impact of an Academic Medical Center Faculty Leadership Development Program. The Journal of Faculty Development. 2020; 34:21-26.

Reed, JL; Dexheimer, JW; Kachelmeyer, AM; Macaluso, M; Alessandrini, EA; Kahn, JA. Information Technology-Assisted Screening for Gonorrhea and Chlamydia in a Pediatric Emergency Department. Journal of Adolescent Health. 2020; 67:186-193.

Kahn, JA. Start Now. Journal of Adolescent Health. 2020; 67:139-144.

Kahn, J; Trotman, G; Vash-Margita, A; Feldman, S. Human Papillomavirus Infection and Cervical Cancer Screening and Prevention in Adolescents. In: Emans SJ; Laufer MR, Ed. Pediatric and Adolescent Gynecology. Philadelphia, PA: Lippincott-Raven; 2019.

Widdice, LE; Bernstein, DI; Franco, EL; Ding, L; Brown, DR; Ermel, AC; Higgins, L; Kahn, JA. Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction. Vaccine. 2019; 37:6832-6841.

Drolet, M; Bénard, É; Pérez, N; Brisson, M; HPV Vaccination Impact Study Group, . Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. The Lancet. 2019; 394:497-509.

Covert, C; Ding, L; Brown, D; Franco, EL; Bernstein, DI; Kahn, JA. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. Human Vaccines and Immunotherapeutics. 2019; 15:1962-1969.

Thomas, R; Dillard, M; Xu, J; Zimet, GD; Kahn, JA. Risk perceptions after human papillomavirus vaccination are not subsequently associated with riskier behaviors or sexually transmitted infections in HIV-infected young women. Human Vaccines and Immunotherapeutics. 2019; 15:1732-1736.

Kahn, JA; Belzer, M; Chi, X; Lee, J; Gaur, AH; Mayer, K; Martinez, J; Futterman, DC; Stier, EA; Paul, ME; et al. Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men. Papillomavirus Research. 2019; 7:52-61.

Mullins, TL K; Idoine, CR; Zimet, GD; Kahn, JA. Primary Care Physician Attitudes and Intentions Toward the Use of HIV Pre-exposure Prophylaxis in Adolescents in One Metropolitan Region. Journal of Adolescent Health. 2019; 64:581-588.

Charlton, BM; Kahn, JA; Sarda, V; Katz-Wise, SL; Spiegelman, D; Missmer, SA; Austin, SB. Maternal Factors and Sexual Orientation-Related Disparities in Cervical Cancer Prevention. Women's Health Issues. 2019; 29:238-244.

Morrow, C; Ding, L; Gorbach, P; Chandler, E; Crumpton, M; Kahn, JA. Rates and Predictors of Human Papillomavirus Vaccination among Young Men Recruited from Urban Clinical and Community Settings. Journal of Men's Health. 2019; 15:e30-e44.

Spinner, C; Ding, L; Bernstein, DI; Brown, DR; Franco, EL; Covert, C; Kahn, JA. Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women. Pediatrics. 2019; 143:e20181902.

Contact Us

A photo of Jessica Kahn.

Jessica A. Kahn, MD, MPH  

Mailing Address:
Division of Adolescent Medicine
3333 Burnet Ave.
MLC 4000
Cincinnati, OH 45229

Phone: 513-636-7764
Fax: 513-636-1129
Email: jessica.kahn@cchmc.org